- CYP1A1/2 and prostaglandin H synthase catalyze reductive activation of inflammatory drug aristolochic acid and that results in DNA adduct formation2000 | Faculty of Science
- Heme peroxidases: structure, function, mechanism and involvement in activation of carcinogens. A review.2000 | Faculty of Science
- Oxidation of xenobiotics by plant microsomes, a reconstituted cytochrome P450 and peroxidase: a comparative study2000 | Faculty of Science
- Aristolochic acids and a renal disease Chinese herbs nephropathy2000 | Faculty of Science
- Enzymatic systems partixipating in biotransformation of phenols2000 | Faculty of Science
- Renal disease caused by chinese herbs, Aristolochic acids and the mechanism of their carcinogenic action2000 | Faculty of Science
- Identification of human enzymes activating carcinogenic aristolochic acids: evidence for reductive activation by CYP1A1 and CYP1A22000 | Faculty of Science
- Molecular study of the carcinogenicity of o-nitroanisole and o-anisidine, carcinogens with unknown mechanism2000 | Faculty of Science
- Oxidation of carcinogenic 2-nitroanisole and 2-anisidine by cytochrome P450 a peroxidases2000 | Faculty of Science
- Carcinogenic 1-phenylazo-2-hydroxynaphthalene (Sudan I, C.I. Solvent Yellow 14) is oxidized by human cytochromes P450 CYP1A1 and CYP1A22000 | Faculty of Science
- Evidence for cytochrome P450-dependent covalent binding of antitumor drug ellipticine to DNA2000 | Faculty of Science
- DNA adducts are formed from ellipticine and ellipticine-human serum albumin (Elli-HSA) in cells transfected with cytochrome P4502000 | Faculty of Science
- DNA adduct formation by the anticancer drug ellipticine in rats determined by 32P-postlabeling2003 | Faculty of Science
- Enzymes biotrasforming pollutants are limiting for construction of bioreactors2003 | Faculty of Science
- Physiological changes of Candida tropicalis population degrading phenol in fed batch reactor.2003 | Faculty of Science
- Evaluation pf 32P-postlabelling as a suitable detection technique for biomonitoring of human DNA adducts2003 | Faculty of Science
- Induction of cytochromes P450 1A1/2 by the anticancer drug ellipticine2003 | Faculty of Science
- Enzymes of yeast Candida tropicalis participate in biodegradation of phenol2003 | Faculty of Science
- Study on organ specificity of CYP1A1 induction by 1-phenylazo-2-hydroxynaphthalene (Sudan I) in rats2003 | Faculty of Science
- Enzymes of yeast Candida tropicalis participating in biodegradation of phenol2003 | Faculty of Science
- The anticancer drug ellipticine acts as an inducer of cytochromes P450 1A1/2 and potentiates its own pharmacological efficiency2003 | Faculty of Science
- The explanation of the inhibition effect of ellipticine on cytochromes P4502003 | Faculty of Science
- The interaction between the anticancer drug ellipticine and cytochromes P450 dictates its pharmacological efficiencies2003 | Faculty of Science
- Peroxidase-mediated ellipticine-DNA adduct formation explains the selective efficiency of this anticancer drug against breast cancer and leukemia2003 | Faculty of Science
- Cytochrome P450-mediated activation of carcinogenic 2-anisidine leads to formation of DNA adducts in vitro and in vivo2003 | Faculty of Science
- Enzymes of Candida tropicalis yeast participate in phenol degradation2003 | Faculty of Science
- Metabolic activation of the suspected human carcinogen 3-nitrobenzanthrone by human hepatic microsomes and recombinant cytochromes P4502003 | Faculty of Science
- 2-Anisidine is a genotoxic carcinogen: evidence for 2-anisidine-DNA adduct formation in vitro a in vivo2003 | Faculty of Science
- Utilization of cytochromes P450 to explain a new mechanism of action of anticancer drug ellipticine2003 | Faculty of Science
- Sudan I metabolism by human cytochrome P450 1A1 is stimulated by microsomal cytochrome b5.2003 | Faculty of Science